Redhill Biopharma
RDHL
#10585
Rank
S$5.2 M
Marketcap
S$1.02
Share price
-0.01%
Change (1 day)
-67.81%
Change (1 year)

Market capitalization of Redhill Biopharma (RDHL)

Market cap: S$5.2 Million

As of April 2026 Redhill Biopharma has a market cap of S$5.2 Million. This makes Redhill Biopharma the world's 10585th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Redhill Biopharma from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026S$5.2 M-30.12%
2025S$7.45 M-38.03%
2024S$12.02 M-68.3%
2023S$37.93 M121.15%
2022S$17.15 M-90.61%
2021S$0.18 B-54.64%
2020S$0.40 B39.6%
2019S$0.28 B34.19%
2018S$0.21 B47.08%
2017S$0.14 B-43.37%
2016S$0.25 B11.51%
2015S$0.23 B49.61%
2014S$0.15 B60.78%
2013S$96.27 M

End of Day market cap according to different sources

On Apr 7th, 2026 the market cap of Redhill Biopharma was reported to be:

S$5.2 Million
by Nasdaq info icon info icon
S$5.2 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Sanofi
SNY
S$146.20 B 2,807,013.39%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
S$387.84 B 7,446,462.92%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$146.89 B 2,820,263.86%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
S$46.36 B 890,155.92%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Taro Pharmaceutical
TARO
S$2.05 B 39,388.77%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel